F. Rouillon

644 total citations
35 papers, 487 citations indexed

About

F. Rouillon is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, F. Rouillon has authored 35 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 7 papers in Pharmacology. Recurrent topics in F. Rouillon's work include Schizophrenia research and treatment (10 papers), Tryptophan and brain disorders (7 papers) and Treatment of Major Depression (7 papers). F. Rouillon is often cited by papers focused on Schizophrenia research and treatment (10 papers), Tryptophan and brain disorders (7 papers) and Treatment of Major Depression (7 papers). F. Rouillon collaborates with scholars based in France, Italy and Austria. F. Rouillon's co-authors include Philip Gorwood, Frédéric Limosin, Christopher Payan, J. Adès, Bruno Falissard, C. Even, Emmanuelle Corruble, Paul Moran, Laurent Gouya and Thomas E. Schläepfer and has published in prestigious journals such as Biological Psychiatry, The British Journal of Psychiatry and Acta Psychiatrica Scandinavica.

In The Last Decade

F. Rouillon

33 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Rouillon France	11	177	152	79	69	68	35	487
Nikos C. Stefanis Greece	13	258 1.5×	135 0.9×	89 1.1×	69 1.0×	66 1.0×	48	609
Jitschak G. Storosum Netherlands	17	314 1.8×	238 1.6×	139 1.8×	65 0.9×	71 1.0×	26	688
Antonio Andreoli Switzerland	10	143 0.8×	231 1.5×	119 1.5×	79 1.1×	111 1.6×	33	569
José Antônio Alves Vilela Brazil	5	210 1.2×	222 1.5×	39 0.5×	57 0.8×	110 1.6×	8	509
Sue Luty New Zealand	13	146 0.8×	207 1.4×	80 1.0×	33 0.5×	74 1.1×	21	441
Rosa Dueñas Spain	12	330 1.9×	170 1.1×	34 0.4×	45 0.7×	36 0.5×	21	525
Xiaomin Zhu China	14	202 1.1×	216 1.4×	80 1.0×	99 1.4×	59 0.9×	24	555
Mei Hung Taiwan	16	214 1.2×	112 0.7×	75 0.9×	143 2.1×	93 1.4×	42	701
Agnes Nocon Germany	11	232 1.3×	341 2.2×	115 1.5×	77 1.1×	133 2.0×	17	720
H Novacenko United States	17	234 1.3×	217 1.4×	108 1.4×	203 2.9×	103 1.5×	29	821

Countries citing papers authored by F. Rouillon

Since Specialization

Citations

This map shows the geographic impact of F. Rouillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Rouillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Rouillon more than expected).

Fields of papers citing papers by F. Rouillon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Rouillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Rouillon. The network helps show where F. Rouillon may publish in the future.

Co-authorship network of co-authors of F. Rouillon

This figure shows the co-authorship network connecting the top 25 collaborators of F. Rouillon. A scholar is included among the top collaborators of F. Rouillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Rouillon. F. Rouillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rouillon, F., et al.. (2017). Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situation. L Encéphale. 43(4). 303–310. 2 indexed citations

Martinotti, Giovanni, Lucía Romo, Alexandra Pham‐Scottez, et al.. (2017). Attention-deficit/hyperactivity disorder symptoms and psychological comorbidity in eating disorder patients. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 23(4). 513–519. 14 indexed citations

Vergnes, Jean‐Noël, Christophe Bedos, Monique Kaminski, et al.. (2013). [Perceived oral health and use of dental services during pregnancy: the MaterniDent study].. PubMed. 25(3). 281–92. 10 indexed citations

Gorwood, Philip, et al.. (2011). The level of associated depression and anxiety traits improves during weight regain in eating disorder patients. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 16(4). e280–e284. 19 indexed citations

Gorwood, Philip, F. Rouillon, C. Even, et al.. (2010). Treatment response in major depression: effects of personality dysfunction and prior depression. The British Journal of Psychiatry. 196(2). 139–142. 56 indexed citations

Goodwin, Guy M., F. Rouillon, & Robin Emsley. (2008). P.2.c.025 Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months. European Neuropsychopharmacology. 18. S338–S339. 10 indexed citations

Goodwin, Guy M., F. Rouillon, & Robin Emsley. (2007). P.2.c.038 Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder. European Neuropsychopharmacology. 17. S361–S362. 8 indexed citations

Limosin, Frédéric, Caroline Dubertret, Laurent Gouya, et al.. (2003). Impulsiveness as the intermediate link between the dopamine receptor D2 gene and alcohol dependence. Psychiatric Genetics. 13(2). 127–129. 47 indexed citations

Limosin, Frédéric, et al.. (2003). Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatrica Scandinavica. 107(5). 331–335. 89 indexed citations

10.

Brunot, A., B. Lachaux, F Casadebaig, et al.. (2002). [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].. PubMed. 28(2). 129–38. 36 indexed citations

11.

Ferreri, M, F. Rouillon, Philippe Nuss, et al.. (2000). What is the schizophrenic patients' level of information about their disease and their treatment?. PubMed. 26 Spec No 1. 15–22. 6 indexed citations

12.

Rouillon, F.. (1998). A double-blind comparison of fluvoxamine and clomipramine in OCD. European Neuropsychopharmacology. 8. S260–S261. 8 indexed citations

13.

Rouillon, F., G Berdeaux, J Chwalow, & Mounir Mesbah. (1998). The efficacy of milnacipran (IxeIR) in the prevention of recurrent depression: Effects on quality of life. European Neuropsychopharmacology. 8. S199–S199. 1 indexed citations

14.

Rouillon, F., et al.. (1997). Epldemiology of panic disorder. Biological Psychiatry. 42(1). 198S–198S. 1 indexed citations

15.

Lejoyeux, Michel & F. Rouillon. (1996). [Suicide and psychotropic drugs].. PubMed. 22 Spec No 4. 40–5. 2 indexed citations

16.

Gorwood, Philip, Marion Leboyer, Bruno Falissard, et al.. (1996). Anticipation in schizophrenia: New light on a controversial problem. European Psychiatry. 11. 221s–222s. 14 indexed citations

17.

Rouillon, F., et al.. (1996). Cross-Cultural Study of Schizophrenia. Psychopathology. 29(2). 85–94. 4 indexed citations

18.

Masson, Cécile, et al.. (1992). [Mental disorders in elderly hospitalized patients. Epidemiological study in an internal medicine department].. PubMed. 21(20). 929–33. 5 indexed citations

19.

Lempérière, T, et al.. (1984). [Comparison of various tools for evaluating depression apropos of a study on Athymil 30 mg].. PubMed. 142(9). 1206–14. 40 indexed citations

20.

Lempérière, T, et al.. (1983). [Prevalence of depressive symptoms in a population of ambulatory schizophrenics].. PubMed. 141(2). 224–36.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact